Pilocarpine for radiotherapy-Induced dry mouth and dry eyes a review of clinical effectiveness, cost-effectiveness, and guidelines
The objective of this report is to summarize the evidence regarding the clinical effectiveness, cost-effectiveness, and evidence-based guidelines regarding the use of pilocarpine for the treatment of dry mouth and dry eyes caused by radiotherapy for cancer of the head or neck
Main Authors: | , |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2020, January 8, 2020
|
Edition: | Version 1.0 |
Series: | CADTH rapid response report: summary with critical appraisal
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references